Saturday, July 04 2009
     
 
   
 
     
 
 
 
 
 
 
     

UNO Healthcare is a licensed distributor of pharmaceuticals devoted to licensing pharmaceuticals and acquiring their rights for distribution to countries in Latin America. Our distribution network relies on our experienced sales representatives and our knowledgeable partners located in each country. We source and supply pharmaceuticals to governmental agencies, hospitals, and physicians.

UNO Healthcare works in partnerships with pharmaceutical and biotechnology companies to establish and deliver NAMED-PATIENT programs. We provide development of PRE-REGISTRATION programs and PRE-MARKETING plans to introduce pharmaceuticals to each specific market.

UNO Healthcare supports physicians and patients in acquiring orphan pharmaceuticals through our diverse contacts worldwide. We also specialize in “hard to find” medicines due to shortages and discontinuations by the manufacturers.

UNO Healthcare’s staff has knowledge in regulatory requirements, technical and clinical support, pharmacovigilance, import/export regulations, logistical management, and storage/handling requirements in order to deal with the complexities associated in shipping pharmaceuticals to countries in Latin America.

 
 
 
   
AUGUST 2008 - UNO HEALTHCARE AND ALEXION PHARMACEUTICALS ENTERS INTO A DISTRIBUTION AGREEMENT OF SOLIRIS FOR BRAZIL
MAY 2007 - UNO HEALTHCARE AND GENZYME ENTERS INTO A DISTRIBUTION AGREEMENT OF CELSIOR FOR BRAZIL
MARCH 2007 - UNO HEALTHCARE AND SHIRE PHARMACEUTICALS ENTERS INTO A DISTRIBUTION AGREEMENT OF ELAPRASE AND REPLAGAL FOR BRAZIL
JUNE 2006 - UNO HEALTHCARE AND BIOMARIN PHARMACEUTICALS ENTERS INTO A DISTRIBUTION AGREEMENT OF NAGLAZYME FOR BRAZIL